Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol® Dispersing

被引:52
作者
DiNunzio, James C. [1 ]
Hughey, Justin R. [1 ]
Brough, Chris [2 ]
Miller, Dave A. [1 ]
Williams, Robert O., III [1 ]
McGinity, James W. [1 ]
机构
[1] Univ Texas Austin, Div Pharmaceut, Austin, TX 78712 USA
[2] DisperSol Technol LLC, Austin, TX USA
关键词
Bioavailability; concentration-enhancing polymers; hydroxypropyl methylcellulose acetate succinate; itraconazole; solid dispersion; supersaturation; thermal processing; IMPROVED ORAL ABSORPTION; HOT-MELT EXTRUSION; GASTROINTESTINAL-TRACT; DRUG ABSORPTION; SOLUBLE DRUG; FORMULATION; SUPERSATURATION; PRECIPITATION; POLYMERS; DELIVERY;
D O I
10.3109/03639041003652973
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objectives: To investigate the ability of KinetiSol (R) Dispersing to prepare amorphous solid dispersions of itraconazole using concentration-enhancing polymers. Methods: Concentration-enhancing nature of several cellulosic polymers (HPMC, hypromellose acetate succinate) was studied using a modified in vitro dissolution test. Solid dispersions were prepared by KinetiSol (R) Dispersing and characterized for solid-state properties using X-ray diffraction and differential scanning calorimetry. Potency and release characteristics were also assessed by high-performance liquid chromatography. Oral bioavailability of lead formulations was also assessed in animal models. Results: Screening studies demonstrated superior concentration-enhancing performance from the hypromellose acetate succinate polymer class. Data showed that stabilization was related to molecular weight and the degree of hydrophobic substitution on the polymer such that HF > MF approximate to LF, indicating that stabilization was achieved through a combination of steric hindrance and hydrophobic interaction, supplemented by the amphiphilic nature and ionization state of the polymer. Solid dispersions exhibited amorphous solid-state behavior and provided neutral media supersaturation using a surfactant-free pH change method. Rank-order behavior was such that LF > MF > HF. Addition of Carbopol 974P increased acidic media dissolution, while providing a lower magnitude of supersaturation in neutral media because of swelling of the high viscosity gel. In vivo results for both lead compositions displayed erratic absorption was attributed to the variability of gastrointestinal pH in the animals. Conclusions: These results showed that production of amorphous solid dispersions containing concentration-enhancing polymers through KinetiSol (R) Dispersing can provide improved oral bioavailability; however, additional formulation techniques must be developed to minimize variability associated with natural variations in subject gastrointestinal physiology.
引用
收藏
页码:1064 / 1078
页数:15
相关论文
共 49 条
[1]   Pharmaceutical Aspects of Polymeric Nanoparticles for Oral Drug Delivery [J].
Bhardwaj, V. ;
Hariharan, S. ;
Bala, I. ;
Lamprecht, A. ;
Kumar, N. ;
Panchagnula, R. ;
Kumar, M. N. V. Ravi .
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2005, 1 (03) :235-258
[2]   The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption .3. Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro [J].
Borchard, G ;
Luessen, HL ;
deBoer, AG ;
Verhoef, JC ;
Lehr, CM ;
Junginger, HE .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) :131-138
[3]  
Breitenbach J., 2009, KALETRA MELTREX STOR
[4]  
Breitenbach J., 2006, AM J DRUG DELIVERY, V4, P61, DOI [10.2165/00137696-200604020-00001, DOI 10.2165/00137696-200604020-00001]
[5]   Comparative interaction of 2-hydroxypropyl-β-cyclodextrin and sulfobutylether-β-cyclodextrin with itraconazole:: Phase-solubility behavior and stabilization of supersaturated drug solutions [J].
Brewster, Marcus E. ;
Vandecruys, Roger ;
Peeters, Jef ;
Neeskens, Peter ;
Verreck, Geert ;
Loftsson, Thorsteinn .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 34 (2-3) :94-103
[6]   Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations [J].
Buchanan, Charles M. ;
Buchanan, Norma L. ;
Edgar, Kevin J. ;
Klein, Sandra ;
Little, James L. ;
Ramsey, Michael G. ;
Ruble, Karen M. ;
Wacher, Vincent J. ;
Wempe, Michael F. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (11) :3100-3116
[7]   Pharmacology of itraconazole [J].
De Beule, K ;
Van Gestel, J .
DRUGS, 2001, 61 (Suppl 1) :27-37
[8]   Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol® dispersing [J].
DiNunzio, James C. ;
Brough, Chris ;
Hughey, Justin R. ;
Miller, Dave A. ;
Williams, Robert O., III ;
McGinity, James W. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2010, 74 (02) :340-351
[9]   Fusion Processing of Itraconazole Solid Dispersions by KinetiSol® Dispersing: A Comparative Study to Hot Melt Extrusion [J].
DiNunzio, James C. ;
Brough, Chris ;
Miller, Dave A. ;
Williams, Robert O., III ;
McGinity, James W. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (03) :1239-1253
[10]   Amorphous Compositions Using Concentration Enhancing Polymers for Improved Bioavailability of Itraconazole [J].
DiNunzio, James C. ;
Miller, Dave A. ;
Yang, Wei ;
McGinity, James W. ;
Williams, Robert O., III .
MOLECULAR PHARMACEUTICS, 2008, 5 (06) :968-980